CCL2 and neoplasm: LNMAT1 is upregulated in bladder cancer, which stimulates lymphangiogenesis and metastases by epigenetically activating CCL2 expression recruiting TAMs into the tumor beds, and facilitating lymphatic metastasis through the excretion of VEGF‐C137.